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Abstract
There are numerous genetic and environmental factors associated significantly with
obesity,  which  could  be  used  as  potential  diagnostic  biomarkers.  The  molecular
mechanisms, development, differentiation, and disease gene expression data provide
crucial insights as these differentially expressed genes could have major effects on diet-
induced obesity and such effect is not seen in animals. Genomics and proteomics are
major branches for better understanding the normal function of the tissues and their
interactions with the environment i.e. characterizing the tissues in which the newly
discovered genes are expressed, helps in understanding the development of tissues,
ageing mechanisms, and signalling routes that enable the tissues to function and also
direct the similitude, parallelism and other levels of aptness betwixt two or more gene
artefacts. It is traditionally known that hypothalamic and brain stem centres are intricate
in  the  mandate  of  food  absorption  and  energy  equilibrium,  but  statistics  on  the
associated governing elements and their genes was scant until the utmost decagon and
have been identified to be strongly expressed in variety of tissues. NPY plays a notable
part in anxiety, tension, corpulence, and vitality homeostasis through incitement of
NPY-Y1 receptors (Y1Rs) in the mind. NPY1R quality is the protein accomplice of
qualities that are utilized as model as a part of mouse and in addition in people. Utilizing
diverse bioinformatics instruments, the relative examination of NPY1R at quality and
additionally at protein level can be assessed for biomarker of stoutness malady. In this
manner, the system science thinks about point to predict the quality of heftiness which
could be taken as a biomarker in human by examining with the quality that already has
been utilized as marker as a part of model life forms.
Keywords: network biology, text mining, obesity, bioinformatics databases and tools
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Creation of networks and all their known associations [1], enabled valuable insights into
human disease and disease therapy. Protein-protein interaction mapping focused on specific
human diseases  which  identified  novel  interactions  among proteins  encoded by  known
disease genes, and have also predicted new disease susceptibility genes. Rapid advances in
network biology indicated that cellular networks are governed by universal laws and offer a
new conceptual framework that could potentially revolutionize our view of biology and
disease pathologies in the twenty-first century [2]. Due to the wide quota of research being
conducted on this topic,  much has been inscribed in the biomedical  literature about the
coalition betwixt genes and diseases. Therefore, obtaining disease–gene coalition from script
is an evident use case for text mining, and disease–gene coalitions have actually formerly been
obtained by postulated co-occurrence-based text-mining structures [3–6]. Text mining is the
discovery by computer of new, previously unknown information, by automatically extracting
information  from  different  written  resources.  The  purpose  of  text  mining  is  to  process
unstructured (textual) information, extract meaningful numeric indices from the text, and,
thus,  make  the  information  contained  in  the  text  accessible  to  the  various  data  mining
(statistical and machine learning) algorithms. As the research on obesity is carried out by large
groups in scientific community, this becomes the problem of big data analytics that is, the
process of examining large data sets containing a variety of data types to uncover hidden
patterns and unknown correlations. Obesity is an abnormal accumulation of body fat, usually
20% or more over an individual’s ideal body weight. Excess bodyweight is the sixth most
important risk factor contributing to the overall burden of disease worldwide. Genetic factors
significantly influence how the body regulates the appetite and the rate at which it turns food
into energy (metabolic rate). A lot is known about the genetic aspects of obesity, but much
more remains to be discovered. The primary goals are to identify the specific genetic variations
and the biologic consequences that are produced, or as commonly put, discovering the genes
and pathways involved in producing phenotypic variation and the factors that influence
obesity [7]. Thus from the present work we would find markers for obesity in humans which
would help in the diagnosis and prognosis of obesity and the same process could find its
applications for other diseases.
2. Network biology and text mining approach to find potential human
biomarkers in obesity
Network science concerns with biological entanglement by condensing composite structures
as elements (nodes) and interactions (edges) betwixt them [8]. In biological structures nodes
are metabolites and macromolecules such as proteins, RNA molecules and gene sequences,
while the edges are physical, biochemical and functional interactions that can be recognised
with a profusion of automation. Creation of networks of genetic disorders and all their known
gene associations [1], or of drugs and all their known protein targets [9], enabled worthwhile
insights into human disease and disease therapy. Protein-protein interaction mapping efforts
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focused on specific human diseases (like ataxia [10, 11], autism [12] and breast cancer [13] have
identified novel interactions among proteins encoded by known disease genes, and have also
predicted new disease susceptibility genes. The common finding among these disease inter-
actomes is the discovery of unexpected relationships between disease genes that initially ap-
peared unrelated [14]. Building and analysing more disease-centric networks is accordingly a
critical step towards deeper understanding of underlying disease mechanisms (http://
ccsb.dfci.harvard.edu/web/www/ccsb/Research/ networks.html). A key aim of postgenomic
biomedical research is to systematically catalogue all molecules and their interactions within
a living cell as shown in Figure 1. There is a comprehensible necessity to comprehend how
these molecules and the interactions betwixt them decide the role of this extremely composite
mechanism, both in detachment and when encompassed by different cells. Fast advances in
system science determine that cell systems are hegemonize by general laws and offer another
calculated structure that could change the perspective of science and infection pathologies in
the twenty-first century [2].
Figure 1. Uproars in Biological Systems and Cellular Networks may stamp genotype-phenotype connections. By com-
municating with each other, qualities and their items from complex cell systems. The connection between upheavals in
system and frameworks properties and phenotypes, for example, Mendelian issue, complex qualities, and tumour,
may be as major as that amongst genotypes and phenotypes [8].
Three distinct approaches have been used to capture interactome networks: (1) compilation or
curation of hitherto prevailing data accessible in the writing, more often than not removed
from one or only a couple sorts of physical or biochemical associations [15]; (2) computational
expectations in light of available “orthogonal” data separated from physical or biochemical
collaborations, for example, arrangement likenesses, quality request protection, co-nearness
and co-nonappearance of qualities in totally sequenced genomes and protein basic data [16];
and (3) orderly, unprejudiced high throughput experimental mapping strategies applied at the
scale of whole genomes or proteomes [17]. These approaches, though compatible, differ greatly
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in the feasible interpretations of the resulting maps. Literature-curated maps extend the benefit
of using already accessible information, but are restricted by the intrinsically variable quality
of the published data, the absence of orderliness, and the absence of describing of negative
data [18, 19]. Computational prediction maps are fast and efficient to implement, and usually
include satisfyingly large numbers of nodes and edges, but are necessarily imperfect because
they use indirect information [20]. While high-throughput maps attempt to report unbiased,
deliberate, and all around controlled information, they were at first all the more difficult to
start, albeit late mechanical methodology predict that close achievement can come within a
couple of years for profoundly reliable, comprehensive protein-protein connection and quality
administrative system maps for human [21]. Content mining is the disclosure by PC of new,
beforehand obscure data, by normally acquiring data from various composed courtesy. A key
part is the association of the acquired data together to frame new truths or new theories to be
viewed as further by a more basic method for examination (http://people.ischool.berkeley.edu/
~hearst/text-mining.html). The reason of text mining is to handle unstructured (literary) data,
extricate important numeric records from the content, and, in this way, make the data required
in the content accessible to the different information mining (factual and machine learning)
techniques as shown in Figure 2. Data can be acquired to get synopses for the words required
in the records or to register outlines for the archives in light of the words contained in them
(http://documents.software.dell.com/statistics/textbook/text-mining# overview).
Figure 2. The approach followed by text mining method in general.
The heterogeneous data types are generated by experiments done. To communicate with these
scientific discoveries natural language is used which is amenable for direct human interpre-
tations. Natural language is the simple human language, different from programming lan-
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guage, through which human talks to computer. Functional information and annotations can
be derived from published text directly or indirectly. Currently databases are only capable of
covering a small fraction of biological context information encountered in the literature. For
bench scientists, published data is the best source for interpreting high-throughput experi-
ments, but automated text processing methods are required to integrate them into the data
analysis workflow. So, the user demands better information access that is beyond just keyword
searches. Moreover, due to rapid growth of information, manual extraction of information is
a difficult task. So, there is a need of an efficient approach that can retrieve the meaningful
information from this vast and unstructured text [22]. Excess bodyweight is the sixth most
important risk factor contributing to the overall burden of disease worldwide; 1.1 billion adults
and 10% of children are now classified as overweight or obese. The main adverse consequences
of being obese are cardiovascular disease, type 2 diabetes, and several cancers as shown in
Figure 3 [23]. The incidence of obesity appears to be levelling in the world and started to be a
big concern in the public health that causes social and economic costs of the twenty-first cen-
tury. The pathogenesis of obesity is complex at all levels of biology as shown in Figure 4 that
is genetics, cell and tissue biology, physiology, and behaviour. The International Diabetes Fed-
eration considers central obesity as a primary evidence of metabolic syndrome, with the ad-
ditional features which include, (1) increased triglyceride levels, (2) increased blood pressure,
(3) increased fasting plasma glucose and (4) reduced HDL-cholesterol [24]. In 1997, there was
serious buoyancy because, for the first time in 25 years, a new drug for the treatment of obesity
had been endorsed by the US Food and Drug Administration (FDA). Then, in April 1996, two
more drugs were starting their way through the acceptance procedure [25, 26]. In June 2013,
the American Medical Association classified obesity as a disease (http://www.medscape.com/
viewarticle/806566).
Figure 3. Consequences of obesity.
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Figure 4. Showing extra calories in fat cells (lipocytes).
A lot is known about the genetic aspects of obesity, but much more remains to be discovered.
Medical genetics is fundamentally interested in understanding the relationship between
genetic variation and human health and disease. The primary goals are to identify the specific
genetic variations and the biologic consequences that are produced, or as commonly put,
discovering the genes and pathways involved in producing phenotypic variation, and the
factors that influence obesity [7]. Network study on genes and proteins offers functional basics
of the complexity of gene and protein, and its interacting partners as shown in Figure 5. Obese
adults and children are more likely to display elevations in plasma fabp4 levels [27, 28]. Pparg
appeared to be a core obesity gene, which interacts with lipid metabolism and inflammation
genes [25]. Genetic variants within FTO (fat mass and obesity associated) have been identified to
exhibit the strongest association with obesity in humans [29–32]. The well-known obesity-
related FTO gene interacts with APOE which in turn, is associated with Alzheimer's disease
[33] and with MC4R, resulting in a higher chance of breast cancer [34]. Gene networks can be
constructed by ensembling previously reported interactions in the literature and various
databases like STRING, DISEASES, etc. [35]. The network could be visualized and constructed
using cytoscape. Cytoscape supported several algorithms for the layout of networks which
included spring embedded layout, hierarchical layout, circular layout and attribute based
layout [36]. It was generally accepted that hypothalamic and brain stem centres are involved
in the regulation of food intake and energy balance but information on the relevant regulatory
factors and their genes was scarce until the last decade [37].
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Figure 5. Genes involved in the leptin-melanocortin pathway that have been associated with monogenic obesity
through their influence on food intake and energy expenditure.
There are numerous genetic factors, like Melanocortin-4 receptor (MC4R), Proopiomelano-
cortin (POMC), Single Minded Gene (SIM1), etc., important in obesity, which can be used as
biomarkers in humans [38]. In the past literature studies, NPY1R was used as a knockout
marker in mouse for obesity but not used as a biomarker in humans [39]. NPY1R (Neuropep-
tide Y Receptor Y1), have been recognized to actively express in variety of tissues, including
trigeminal V ganglion, heart, brain, spleen, lungs, skeletal muscle, kidney and embryo, in
embryonic as well as in postnatal Theiler stages as adamanted by RNA in situ and Northern
blot [38, 40]. Therefore, interacting patterns of NPY1R were analysed using STRING version
10.0 [41] as shown in Figure 6.
Figure 6. The interacting patterns of NPY1R in Homo sapiens obtained from known (curated databases and experimen-
tally determined), predicted (gene-neighbourhood, gene fusions and gene co-occurrence) and other (text mining, pro-
tein homology and co-expression) interactions.
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As NPY1R was used as an obesity marker in obesity model organisms like mouse and rat,
therefore their interactions were also observed using STRING version 10.0 as shown in
Figures 7 and 8.
Figure 7. The interacting patterns of NPY1R in Mus musculus obtained from known (curated databases and experimen-
tally determined), predicted (gene-neighbourhood, gene fusions and gene co-occurrence) and other (text mining, pro-
tein homology and co-expression) interactions.
Figure 8. The interacting patterns of NPY1R in Rattus norvegicus obtained from known (curated databases and experi-
mentally determined), predicted (gene-neighbourhood, gene fusions and gene co-occurrence) and other (text mining,
protein homology and co-expression) interactions.
Homo sapiens Mus musculus Rattus norvegicus
Functional partners Score Functional partners Score Functional partners Score
NPY 0.998 Npy 0.992 Npy 0.993
PPY 0.993 Gal 0.974 Gal 0.973
GAL 0.992 Pyy 0.965 Pyy 0.964
ppy 0.964 pmch 0.946 ppy 0.941
Table 1. Lists the top scoring functional partners in Homo sapiens, Mus musculus and Rattus norvegicus.
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After finding the functional partners for NPY1R in human and obesity model organisms that
is, mouse and rat, top four high scoring genes were considered and further their functional
partners were retrieved from STRING version 10.0 as shown in Table 1. The score of the
functional partners were mostly on the basis of known experimental and curated databases
interactions, other interactions like text mining interactions.
The networks obtained from STRING for all the interactions were merged separately for three
organisms using cytoscape version 2.7.0 as shown in Figures 9–11.
Figure 9. The merged network for Homo sapiens interacting functional partners. The green colour node shows the main
input NPY1R for which the functional partners were searched. The sea green nodes show the top scoring functional
partners of NPY1R.
Figure 10. The merged network for Mus musculus interacting functional partners. The green colour node shows the
main input NPY1R for which the functional partners were searched. The sea green nodes show the top scoring func-
tional partners of NPY1R.
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Figure 11. The merged network for Rattus norvegicus interacting functional partners. The green colour node shows the
main input NPY1R for which the functional partners were searched. The sea green nodes show the top scoring func-
tional partners of NPY1R.
Then these merged networks were manually analysed and it was found that there are 11 genes
which were common in the merged networks of the three considered organisms. The common
genes were npy, ppy, pdyn, gal, pomc, npy1r, sst, galr1, npy2r, ccl28 and npy5r. Then these common
genes were used to find disease-gene associations, in this case, association of common genes
with obesity using DISEASES web source [42] that integrates evidence on disease-gene
associations from automatic text mining, manually curated literature, cancer mutation data,
and genome-wide association studies was found. From DISEASES web source 8 genes out of
11 were found related to obesity, where 7 genes had evidence from text mining and 1 gene had
database evidence and no gene was found from experimental results as shown in Table 2.
Gene Name Disease Evidence Confidence
NPY Obesity Text mining ****
NPY1R Obesity Text mining **
NPY2R Obesity Text mining **
NPY5R Obesity Text mining **
PPY Obesity Text mining ****
GAL Obesity Text mining **
CCL28 Obesity Text mining **
POMC Obesity Database ****
Table 2. List of disease-genes associations acquired from automatic text mining of the biomedical literature and
DISEASES web source, where the confidence of each association is signified by stars, where ***** is the highest
confidence and * is the lowest.
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All the above gathered data was cross checked for networks and its disease associations using
KEGG pathway [43, 44] which is a collection of manually drawn pathway maps representing
the knowledge on the molecular interaction and reaction networks and Online Mendelian
Inheritance in Man (OMIM) [45] which is a comprehensive, authoritative compendium of
human genes and genetic phenotypes. Two pathways were found in humans which showed
roles in obesity containing the respective genes obtained after disease-gene associations as
shown in Figures 12 and 13.
Figure 12. Regulation of lipolysis in adipocytes. This pathway shows the presence of genes NPYR and NPY in the fed
state. This pathway also shows the presence of genes like FABP but in the fasting state and is the known marker for
obesity [46–60].
Thus, from the above work we could conclude that NPY, NPY1R, NPY2R, NPY5R and POMC
which in the past literature studies were used as knockout markers in mouse and rats for
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obesity but not used as a biomarker in humans could be considered as potential biomarkers
for obesity in humans. By finding optimal biomarkers, diagnostic criteria for cardiovascular
diseases can be refined in the obese beyond “traditional” risk factors to identify early patho-
logic processes. Identifying diagnosis and prognosis biomarkers from expression profiling
data is of great significance for achieving personalized medicine and designing a therapeutic
strategy in complex diseases. A similar methodology can be used to predict other biomarkers
for different diseases. For progression and maintenance of life saving diseases, the expression
data of biomarkers could be used in future applications.
Figure 13. Adipocytokine signalling pathway. This pathway again marks the presence of NPY and POMC in obesity
along with already known markers of obesity like PPAR and TNF α [61–74].
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